Latham & Watkins Advises WestView Capital Partners on Growth Investment in PharmaLink

PharmaLink, a leading pharmaceutical reverse logistics platform, announced that it has received a growth investment from WestView Capital Partners, a Boston-based growth equity firm focused on middle market growth companies.

Latham & Watkins LLP represented WestView Capital Partners in the investment with a corporate deal team led by Boston partner Ryan McCarthy and associate Laki Triantafylidis, with associates Dante Spurlock, Cherrie Wang, and Alberto Cabrera Rivera. Advice was also provided on tax matters by Bay Area partner Grace Lee, with associate Gregory Conyers; on finance matters by Boston partner Alex Harris, with associates Jake Hummer and Daniel Barks; on healthcare matters by Bay Area partner Betty Pang, with associate Yanyan Zhou; on FDA matters by Washington, D.C. partner Bill McConagha, with associate Evan Miller; on intellectual property matters by associates Deborah Hinck and Victoria Allen; on benefits matters by Chicago partner Benjamin Rosemergy, with associates Juliet Rognlie and Tayler Evan Daniels; on antitrust matters by Washington, D.C. partner Patrick English, with associate Ben Bouwman; on labor matters by Chicago partner Nineveh Alkhas; and on insurance matters by Los Angeles partner Drew Levin and San Diego/Los Angeles counsel Hannah Cary, with associate Enrique Covarrubias.